Gencor Pacific has received a U.S. patent (US 10,576,118 B2) for its fenugreek extract, Testofen, which is standardized to a 50% minimum content of Fenuside.
Photo © iStockphoto.com/monkeybusinessimages
Gencor Pacific (Irvine, CA) has received a U.S. patent (US 10,576,118 B2) for its fenugreek extract, Testofen, which is standardized to a 50% minimum content of Fenuside. The patent was granted for the improvement of sexual function, reducing further decline of sexual hormones, and improvement in sexual hormonal levels in healthy aging males.
“We have made a significant investment into the clinical validation of Testofen, and receiving this patent further progresses our commitment and intellectual property supporting this superior fenugreek extract,” said Chase Shryoc, vice president of sales of Gencor, in a press release. “Testofen is the perfect addition for product formulations designed to support healthy sexual function, and performance.”
A number of double-blind placebo-controlled clinical trials have demonstrated the efficacy and safety of Testofen. The most recently published trial found that supplementation with Testofen significantly reduced body fat, increased muscle mass, and increased testosterone levels.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.